Biosimilars Market worth $66.9 billion
CHICAGO, June 15, 2023 /PRNewswire/ — The biosimilars industry is poised for significant growth and innovation in the near future. Biosimilars, which are highly similar and interchangeable versions of approved biologic drugs, offer several advantages such as increased patient access to affordable treatments, cost savings for healthcare systems, and enhanced competition in the pharmaceutical market. … Read more